Newron Pharmaceuticals S.p.A.
Biopharmaceutical company developing therapies for nervous system disorders and pain.
NWRN | SW
Overview
Corporate Details
- ISIN(s):
- IT0004147952
- LEI:
- 8156002F8C11F80A9740
- Country:
- Italy
- Address:
- VIA MEUCCI, 3, 20091 BRESSO
- Website:
- https://www.newron.com/
- Sector:
- Manufacturing
Description
Newron Pharmaceuticals is a biopharmaceutical company focused on the research and development of novel therapies for diseases of the central and peripheral nervous system (CNS) and pain. The company's portfolio includes Xadago® (safinamide), a globally partnered treatment for Parkinson's disease. Its clinical-stage pipeline is centered on CNS disorders, with a key candidate, evenamide, under investigation for the treatment of schizophrenia.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-02 02:00 |
EQS-News: Newron appoints Margarita Chavez as board advisor
|
English | 9.5 KB | ||
| 2023-10-02 02:00 |
EQS-News: Newron ernennt Margarita Chavez zur Beraterin des Verwaltungsrates
|
German | 11.5 KB | ||
| 2023-08-04 02:00 |
EQS-Adhoc: Newron veröffentlicht Halbjahresergebnisse 2023 und F&E-Update
|
German | 14.6 KB | ||
| 2023-08-04 02:00 |
EQS-News: Newron announces H1 2023 results and provides R&D update
|
English | 20.5 KB | ||
| 2023-08-04 02:00 |
EQS-News: Newron veröffentlicht Halbjahresergebnisse 2023 und F&E-Update
|
German | 23.8 KB | ||
| 2023-05-15 02:00 |
EQS-News: Newron presents exciting new data from study 014/015 at CINP World C…
|
English | 17.3 KB | ||
| 2023-05-15 02:00 |
EQS-News: Newron präsentiert eindrucksvolle neue Daten der Studie 014/015 auf d…
|
German | 21.0 KB | ||
| 2023-05-03 02:00 |
EQS-News: Newron to present at the 34th CINP World Congress of Neuropsychopharm…
|
English | 13.0 KB | ||
| 2023-05-03 02:00 |
EQS-News: Newron präsentiert auf dem 34. CINP World Congress of Neuropsychophar…
|
German | 15.8 KB | ||
| 2023-05-02 02:00 |
EQS-News: Newron announces Senior Management Team changes
|
English | 9.5 KB | ||
| 2023-05-02 02:00 |
EQS-News: Newron kündigt Veränderungen im Senior Management Team an
|
German | 11.0 KB | ||
| 2023-05-02 02:00 |
EQS-Adhoc: Newron kündigt Veränderungen im Senior Management Team an
|
German | 7.6 KB | ||
| 2023-04-18 02:00 |
EQS-News: Newron announces AGM 2023 results
|
English | 4.9 KB | ||
| 2023-04-18 02:00 |
EQS-News: Newron gibt Ergebnisse der Generalversammlung 2023 bekannt
|
German | 5.4 KB | ||
| 2023-03-28 02:00 |
EQS-News: Newron presents six-month interim data from the first 100 patients ra…
|
English | 12.3 KB |
Automate Your Workflow. Get a real-time feed of all Newron Pharmaceuticals S.p.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Newron Pharmaceuticals S.p.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Newron Pharmaceuticals S.p.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
